logo
  Join        Login             Stock Quote

Covidien (COV) Raises Revenue View After Better-Than-Expected 1Q

 January 25, 2013 06:57 AM
 


(By Balachander) Covidien Plc (NYSE: COV) posted better-than-expected quarterly earnings helped by strong sales growth at its medical devices segment and the Ireland-based developer of healthcare products lifted its outlook for 2013.

Excluding items, earnings per share declined 2.7 percent to $1.10, beating Wall Street projections of $1.06.

Net earnings were nearly flat at $493 million for the first quarter.

Sales increased 5.5 percent to $3.06 billion, better than consensus estimate of a growth of 3.40 percent. Medical devices sales increased 8 percent, while pharmaceuticals sales were flat. Medical supplies sales grew 2 percent.

[Related -S&P Buys That Pass The Buffett Test]

Covidien said it continued to generate above-market growth in a number of key categories at its medical devices segment, including stapling, energy, airway and ventilation.

Gross margin shrank 1.2 percentage points to 57.5 percent. Non-GAAP declined 1.3 percentage points to 57.5 percent.

Selling, general and administrative expenses increased 3.7 percent and Research and development expenses also rose 3.5 percent.

Looking ahead for the full year, the company now forecasts net sales growth between 5 percent and 8 percent versus 3 percent to 6 percent rise projected earlier, while analysts expect an increase of 4.70 percent.

COV shares, which have been trading in the 52-week range of $48.22 to $61.69, ended at $61.67 on Thursday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageSector Rotation Model Stays Bullish, But Neutral Rankings And Technical Resistance Flash Caution

Last week, stocks cycled bullish yet again. In fact, the S&P 500, NYSE Composite, and NASDAQ each closed at read on...

article image2000 More Points To Go?

15 years is a long time to wait for a 1%/yr read on...

article imageMixed Economic Signals So Far For The US In Q2

The outlook for first-quarter US growth has been cut to the bone, according to the current estimate of the read on...

article imageRetirees Will Need Some Income

There is more to retirement planning than “saving more” or “working read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.